Title Biomarkers- APSC Consensus & Future Use Case in Diabetes Mellitus and COVID-19
Date 31 July 2020, Friday
Time 1200 - 1330 Singapore Time / 1300 - 1430 Japan Time / 0400 - 0530 GMT




REGISTER NOW

Registration is on first-come-first-served basis.
By registering for the Webinar, you agree to our Privacy Policy

Topics

APSC Consensus for Assessment of ACS Using high sensitivity Troponin T in ED - Assoc Prof Inoue Kenji

Implementation of 0/1 hour algorithm in Australia - The Real World Study, RAPID-TnT - Dr Cynthia Papendick

Role of NT-proBNP in T2DM patient - The ADOPT study - Dr Chanchal Chandramouli 

COVID-19 Serology Tests - The Evidence & Future Use Case - Assoc Prof David Lye


Chair

Adj Assoc Prof Jack Tan
Deputy Head & Senior Consultant
National Heart Centre Singapore
President, Asian Pacific Society of Cardiology
Singapore

Speakers

Assoc Prof Inoue Kenji
Associate Professor, Department of Cardiology
Juntendo University Nerima Hospital
Japan

Dr Cynthia Papendick
Emergency Physician 
Royal Adelaide Hospital
Australia

Dr Chanchal Chandramouli 
Clinical Research Fellow
National Heart Centre Singapore
Singapore

Dr David Lye
Director, Infectious Disease Research and Training Office
National Centre for Infectious Diseases
Singapore

Panelists

Prof Evangelos Giannitsis
Senior Physician, Clinic for Cardiology, Angiology, Pneumology
Medical Director, Chest Pain Unit
Deputy Director, Private Outpatient Prof. Dr. HA Katus
Research Group Head, AG Cardiac Biomarker
University Hospital Heidelberg
Germany


Assoc Prof Sazzli Kasim 
Cardiologist, Professor of Medicine and Hospital Director
UiTM Medical Specialist Centre
Malaysia

Dr Laila Abdel Wareth
Chief, Clinical Pathology
Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi
United Arab Emirates

Supported by


>